The page is the record's research on the issuer — no analyst, no rating, no view.

Noile-Immune Biotech Inc. (4893) — research page

JP · jp-cm-kg/TSE-GROWTH/4893 · as of 2026-11-06

Identity and listing

The issuer is Noile-Immune Biotech Inc., listed on the Growth Market under ticker 4893. The ISIN is not on the record. The LEI is not on the record. The security type is Corporate. The segment is not on the record. The sector is 3250 Pharmaceutical. The jurisdiction is Japan (EDINET domestic filer). The listing status is listed, not halted.

fieldvaluesource · read date
nameNoile-Immune Biotech Inc.source · 2026-11-06
exchangeGrowth Marketsource · 2026-11-06
ticker4893source · 2026-11-06
ISINnot on the record
LEInot on the record
security typeCorporatesource · 2026-11-06
segmentnot on the record
sector3250 Pharmaceuticalsource · 2026-11-06
jurisdictionJapan (EDINET domestic filer)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 6 filings in the twelve months to 2026-11-06, across 3 filing days. The filings comprise 1 ad hoc, 3 regulatory filings and 2 results. The median gap between filing days is 71.5 days. The latest filing is dated 2026-08-13, is of type regulatory filing, and is 85 days before the record date. The Growth Market median cadence is 42 days across 598 issuers, with a median of 8.0 filings and a median latency of 85.0 days. The 3250 Pharmaceutical sector median cadence is 49.5 days across 80 issuers, with a median of 8.0 filings and a median latency of 85.0 days.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer671.585
exchange median: Growth Market (598 issuers)84285
sector median: 3250 Pharmaceutical (80 issuers)849.585
datetypecategoryfiling
2026-08-13regulatory_filing135確認書
2026-08-13results半期報告書 (half-year report)半期報告書-第12期(2026/01/01-2026/12/31)
2026-03-30ad_hoc臨時報告書 (extraordinary report)臨時報告書
2026-03-23regulatory_filing135確認書
2026-03-23regulatory_filing235内部統制報告書-第11期(2025/01/01-2025/12/31)

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is 有限責任監査法人トーマツ. Its location is not on the record. Auditor changes are not on the record.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as the market has no lifecycle type map yet. The issuer is listed and not halted.

Orderability

For Qualified Institutional Investors, the outcome is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.

client categoryoutcome
Qualified Institutional Investorsnot determinable: the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope

rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations pages read.

Open research

One openly published research note is on the record, by FISCO Ltd., dated 2025-05-26.

datepublishernotekind
2025-05-26FISCO Ltd.Noile-Immune Biotechindependent

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The vintage is not sealed. No issuer years are sealed. The market's earliest sealed date is not on the record, and the live record began is not on the record.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
10.2
https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
10.3
https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4893 (the disclosure lines)
10.4
https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
10.5
https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSP4 (the auditor)
10.6
https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://www.fisco.co.jp/wordpress/wp-content/uploads/FISCO/noile-immune20250526.pdf (open research)
10.8
https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4893 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"4893","exchange":"Growth Market"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:03e33f91486fc51b.